Browsing by Author GOH BOON CHER

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 1 to 20 of 66  next >
Issue DateTitleAuthor(s)
2014A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057HBible, K.C.; Suman, V.J.; Molina, J.R.; Smallridge, R.C.; Maples, W.J.; Menefee, M.E.; Rubin, J.; Karlin, N.; Sideras, K.; Morris III, J.C.; McIver, B.; Hay, I.; Fatourechi, V.; Burton, J.K.; Webster, K.P.; Bieber, C.; Traynor, A.M.; Flynn, P.J.; Goh, B.C. ; Isham, C.R.; Harris, P.; Erlichman, C.
2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Lam, K.C.; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.; Goh, B.C. ; Soo, R.; Wang, L.Z.; Tan, E.H.; Leong, S.S.
2006A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancerSoo, R.A.; Wang, L.Z.; Tham, L.S.; Yong, W.P.; Lim, H.L.; Lee, S.C.; Goh, B.C. ; Lee, H.S ; Boyer, M.; Millward, M.; Beale, P.; Liang, S.
15-Aug-2011A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinomaLim, W.-T. ; Ng, Q.-S.; Ivy, P.; Leong, S.-S.; Singh, O.; Chowbay, B.; Gao, F.; Thng, C.H.; Goh, B.-C. ; Tan, D.S.-W.; Koh, T.S.; Toh, C.-K.; Tan, E.-H. 
2003A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasmaWang, L.Z.; Goh, B.C. ; Lee, S.C.; Wang, L.Z.; Khoo, Y.M.; Lee, H.S. ; Grigg, M.E.
2007A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasmaZhang, N. ; Goh, B.C. ; Khoo, Y.M.; Lee, H.S. ; Yeo, W.
2004Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in T1 and T2 nasopharyngeal carcinomaLu, J.J.; Shakespeare, T.P.; Tan, L.K.S.; Goh, B.C. ; Cooper, J.S.
2004Adjuvant High-Dose Rate Brachytherapy after Chemoradiation for Treatment of Early T-Stage Nasopharyngeal CarcinomaLu, J.J.; Shakespeare, T.; Back, M.; Mukherjee, R.; Wynne, C.J.; Goh, B.C. ; Tan, K.S.L. ; Tiong, C.E.
2004Adjuvant High-Dose Rate Brachytherapy after Chemoradiation for Treatment of Early T-Stage Nasopharyngeal CarcinomaLu, J.J.; Shakespeare, T.; Back, M.; Mukherjee, R.; Wynne, C.J.; Goh, B.C. ; Tan, K.S.L. ; Tiong, C.E.
2010AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Huynh, H ; Ngo, V.C.; Soo, K.C. ; Koong, H.N. ; Poon, D.; Choo, S.P.; Toh, H.C. ; Thng, C.H.; Chow, P.; Ong, H.S. ; Chung, A.; Goh, B.C. ; Smith, P.D.
2008Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHuynh, H.; Yu, K.; Wu, J.; Lee, M.H.; Hor, H.; Soo, K.C.; Toh, H.C.; Tan, P.; Salto-Tellez, M. ; Chow, P.K.H.; Lee, C.K.; Soong, R. ; Goh, B.C. ; Lee, H.S. ; Somani, A.; Tan, P.H. ; Palanisamy, N.; Kalpana, R.
2008Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHuynh, H. ; Yu, K.; Wu, J.; Lee, M.H.; Hor, H.; Soo, K.C. ; Toh, H.C. ; Tan, P. ; Salto-Tellez, M. ; Chow, P.K.H. ; Lee, C.K.; Soong, R. ; Goh, B.C. ; Lee, H.S. ; Somani, A.; Tan, P.H. ; Palanisamy, N.; Kalpana, R.
2006Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expressionSoo, R.A.; Mow, B.; Goh, B.-C. ; Hsu, S. ; Loh, K.S. ; Tan, L. ; Wu, J.; Aggarwal, A.; Tan, P.; Tao, Q.; Hsieh, W.; Soon, W.L.; Lai, Y.F.; Putti, T. ; Tan, K.B. 
2006Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expressionSoo, R.A.; Mow, B.; Goh, B.-C. ; Hsu, S. ; Loh, K.S. ; Tan, L. ; Wu, J.; Aggarwal, A. ; Tan, P.; Tao, Q.; Hsieh, W.; Soon, W.L.; Lai, Y.F.; Putti, T. ; Tan, K.B. 
2006Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expressionSoo, R.A.; Wu, J.; Aggarwal, A.; Tao, Q.; Hsieh, W.; Putti, T. ; Tan, K.B.; Soon, W.L.; Lai, Y.F.; Mow, B.; Hsu, S. ; Loh, K.S. ; Tan, L.; Tan, P.; Goh, B.-C. 
2005Clinical and molecular characteristcs of hereditary non-polyposis colorectal cancer families in Southeast AsiaLee, S.-C.; Gou, J.-Y.; Lim, R.; Soo, R.; Goh, B.-C. ; Koay, E. ; Salto-Tellez, M. ; Leong, A. 
Sep-2013Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelinesD'Cruz, A.; Lin, T.; Anand, A.K.; Atmakusuma, D.; Calaguas, M.J.; Chitapanarux, I.; Cho, B.C.; Goh, B.C. ; Guo, Y.; Hsieh, W.S.; Hu, C.; Kwong, D.; Lin, J.C.; Lou, P.J.; Lu, T.; Prabhash, K.; Sriuranpong, V.; Tang, P.; Vu, V.V.; Wahid, I.; Ang, K.K.; Chan, A.T.
Sep-2000Design of phase I and II clinical trials in oncology and ethical issues involvedGoh, B.C. 
2007Detection of epidermal growth factor receptor variations by partially denaturing HPLCChin, T.M. ; Soo, R. ; Lee, S.C.; Goh, B.C. ; Salto-Tellez, M. ; Anuar, D.; Ahmad, B.; Li, W.Q.; Iacopetta, B.; Kawakami, K.; Segal, A.
2007Detection of epidermal growth factor receptor variations by partially denaturing HPLCChin, T.M.; Soo, R.; Lee, S.C.; Goh, B.C. ; Salto-Tellez, M. ; Anuar, D.; Ahmad, B.; Soong, R. ; Li, W.Q.; Iacopetta, B.; Kawakami, K.; Segal, A.